Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Investigating the effect of aspirin in breast cancer
IRCT20241015063367N1Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Oct 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aspirin in breast cancer, sponsored by Kerman University of Medical Sciences. Started Oct 2024; status: completed.
02
Drugs
aspirin
03
Conditions
breast cancer
Beyond the preview
Go deeper on IRCT20241015063367N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241015063367N1.